Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 24% ± 8% | |
astrocyte | 6 studies | 26% ± 9% | |
microglial cell | 5 studies | 24% ± 5% | |
epithelial cell | 5 studies | 34% ± 8% | |
macrophage | 5 studies | 22% ± 6% | |
non-classical monocyte | 4 studies | 23% ± 8% | |
fibroblast | 4 studies | 18% ± 3% | |
glutamatergic neuron | 4 studies | 45% ± 18% | |
oligodendrocyte precursor cell | 4 studies | 28% ± 9% | |
monocyte | 4 studies | 19% ± 2% | |
oligodendrocyte | 4 studies | 24% ± 3% | |
classical monocyte | 3 studies | 23% ± 4% | |
myeloid cell | 3 studies | 16% ± 0% | |
ciliated cell | 3 studies | 21% ± 3% | |
GABAergic neuron | 3 studies | 48% ± 7% | |
dendritic cell | 3 studies | 23% ± 6% | |
abnormal cell | 3 studies | 28% ± 9% | |
basal cell | 3 studies | 27% ± 7% | |
goblet cell | 3 studies | 32% ± 18% | |
transit amplifying cell | 3 studies | 26% ± 13% | |
interneuron | 3 studies | 38% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4938.37 | 1445 / 1445 | 100% | 95.00 | 183 / 183 |
liver | 100% | 3243.84 | 226 / 226 | 100% | 49.99 | 406 / 406 |
ovary | 100% | 5192.68 | 180 / 180 | 100% | 101.79 | 430 / 430 |
prostate | 100% | 4970.94 | 245 / 245 | 100% | 85.35 | 502 / 502 |
skin | 100% | 6846.68 | 1809 / 1809 | 100% | 90.28 | 472 / 472 |
stomach | 100% | 3860.42 | 359 / 359 | 100% | 114.58 | 286 / 286 |
uterus | 100% | 5147.25 | 170 / 170 | 100% | 84.59 | 459 / 459 |
breast | 100% | 4580.29 | 459 / 459 | 100% | 89.65 | 1117 / 1118 |
lung | 100% | 4781.40 | 578 / 578 | 100% | 86.13 | 1153 / 1155 |
intestine | 100% | 5030.37 | 966 / 966 | 100% | 111.77 | 526 / 527 |
kidney | 100% | 4157.06 | 89 / 89 | 100% | 68.30 | 899 / 901 |
bladder | 100% | 4834.00 | 21 / 21 | 100% | 91.21 | 502 / 504 |
pancreas | 100% | 2954.70 | 328 / 328 | 99% | 73.87 | 177 / 178 |
brain | 99% | 3942.96 | 2626 / 2642 | 100% | 75.97 | 705 / 705 |
thymus | 100% | 5039.89 | 653 / 653 | 99% | 62.97 | 601 / 605 |
adrenal gland | 100% | 4879.96 | 258 / 258 | 99% | 66.29 | 227 / 230 |
adipose | 100% | 4324.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 64.61 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 39.03 | 29 / 29 |
muscle | 100% | 2847.34 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4769.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 83.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.10 | 1 / 1 |
blood vessel | 100% | 4121.22 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3090.61 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3475.23 | 906 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051453 | Biological process | regulation of intracellular pH |
GO_0070863 | Biological process | positive regulation of protein exit from endoplasmic reticulum |
GO_0007155 | Biological process | cell adhesion |
GO_0001666 | Biological process | response to hypoxia |
GO_0072657 | Biological process | protein localization to membrane |
GO_2000010 | Biological process | positive regulation of protein localization to cell surface |
GO_0070072 | Biological process | vacuolar proton-transporting V-type ATPase complex assembly |
GO_0006909 | Biological process | phagocytosis |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005515 | Molecular function | protein binding |
Gene name | TM9SF4 |
Protein name | Transmembrane 9 superfamily member 4 (Tumor cannibalism associated protein 1) Transmembrane 9 superfamily member |
Synonyms | KIAA0255 hCG_38809 TUCAP1 |
Description | FUNCTION: Associates with proteins harboring glycine-rich transmembrane domains and ensures their efficient localization to the cell surface . Regulates the assembly and activity of V-ATPase in colon cancer cells via its interaction with V-type proton ATPase subunit H (ATP6V1H) and contributes to V-ATPase-mediated pH alterations in cancer cells which play an important role in drug resistance and invasiveness of colon cancer cells . Plays an important role in an atypical phagocytic activity of metastatic melanoma cells called cannibalism and is involved in the pH regulation of the intracellular vesicles in tumor cells . . |
Accessions | ENST00000398022.7 ENST00000442842.5 ENST00000217315.9 A0A0C4DFM1 ENST00000450829.5 Q92544 F2Z2L1 |